US drug approvals
83 approvals with a product on the US market
- Gabapentin ANDA219814 · approved 6 Mar 2026
- Dicyclomine Hydrochloride ANDA218310 · approved 6 Jun 2025
- Doxycycline ANDA217098 · approved 27 Jan 2025
- Busulfan ANDA215235 · approved 11 Sep 2024
- Ticagrelor ANDA208599 · approved 16 Aug 2024
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.